Sort releases Relevance Date of release
|
Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis
, Research / Development, Nanion Technologies GmbH
Nanion Technologies is one of the leading providers of high quality automated patch clamp systems. Nanion's efficient and versatile products drastically improve...
|
Nanion celebrates its 10th anniversary - still with a strong focus on new innovation
, Research / Development, Nanion Technologies GmbH
10 years ago, Nanion Technologies started out in a small loft at the Institute of Physiology of Ludwig-Maximilian’s University in Munich. Since then, Nanion has...
|
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users
, Research / Development, Nanion Technologies GmbH
Nanion’s ion channel screening platform, the SyncroPatch 96, has been well received within the pharmaceutical industry during the past 12 months. Experienced automated...
|
Nanion’s Patchliner exceptionally well received by academic ion channel core facilities
, Research / Development, Nanion Technologies GmbH
The new year has started well for Nanion; in the first weeks of 2011 more than five Patchliners were sold and shipped to academic institutions intended for advanced...
|
|
Final success in Nanion's opposition against Molecular Devices patent - "Increased freedom to operate for everyone in automated patch clamping"
, Company-internal, Nanion Technologies GmbH
Nanion Technologies GmbH (Nanion), a supplier of automated, parallel patchclamp systems based in Munich, Germany, today announced that a Board of Appeal of the European...
|
Nanion is winner of the Deutscher Gründerpreis 2009
, Company-internal, Nanion Technologies GmbH
The Deutscher Gründerpreis is the most important award for outstanding entrepreneurs in Germany and recognizes entrepreneurial role models whose companies are at...
|
Nanion and Axiogenesis present parallel patch clamp recordings of action potentials from Cor.At cardiomyocytes
, Research / Development, Nanion Technologies GmbH
Stem cell derived cardiomyocytes have tremendous potential for cardiac safety testing of drug candidates. By offering an authentic cellular environment they are...
|
Nanion's SyncroPatch 96 validated with various targets and cells
, Research / Development, Nanion Technologies GmbH
The SyncroPatch 96, a high quality, high throughput patch clamp ion channel screening platform, shows impressive results with a wide variety of ion channels targets...
|
|
Nanion opens US-office in New Jersey
, Research / Development, Nanion Technologies GmbH
Nanion today announces the opening of Nanion Technologies Inc. with headquarters in North Brunswick, NJ, USA. To support the increasing demand of Nanion’s products,...
|
|
Nanion nominated for The German Industry's Innovation Award
, Research / Development, Nanion Technologies GmbH
Nanion is again nominated for a prestigious innovation award, due its impressive product portfolio of automated patch clamp systems. More than 350 companies competed...
|
|
Nanion's Port-a-Patch is used for bilayer research and education at the Technical University of Munich
, Research / Development, Nanion Technologies GmbH
Starting in 2008, Nanion's Port-a-Patch is being used in education and research at the Institute for Biomolecular Systems and Bioelectronics, Department of Physics...
|
|
Nanion increases throughput and cuts costs with a new industrial 96-channel patch clamp screening robot
, Medical Technology, Nanion Technologies GmbH
Today, Nanion announces the late-stage development of a new automated patch clamp platform: the SyncroPatch 96. Developed to meet the throughput demands of industrial...
|
|
Nanion erhöht den Durchsatz und senkt die Kosten in der Ionenkanal Analyse mit einem neuen 96-Kanal Patch Clamp Automaten für die Pharmaindustrie
, Medical Technology, Nanion Technologies GmbH
Nanion gibt heute die Entwicklung des SyncroPatch 96 bekannt, eine neue, hoch-parallele Patch Clamp Plattform. Das Messsystem wurde entwickelt, um den Anforderungen...
|
|
Automated internal perfusion with the Port-a-Patch
, Miscellaneous, Nanion Technologies GmbH
Nanion Technologies introduces the Internal Perfusion System for the Port-a-Patch; a completely unique device for rapid, continuous and automated exchange of internal...
|
|
Nanion continues opposition against Molecular Devices patent - "a precautionary measure"
, Miscellaneous, Nanion Technologies GmbH
Nanion Technologies GmbH, a supplier of automated, parallel patch-clamp systems based in Munich, Germany, today announced that they would appeal the decision of...
This search as:
Categories
All categories
